GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » Beneish M-Score

Sisram Medical (HKSE:01696) Beneish M-Score : -2.68 (As of May. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.68 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Sisram Medical's Beneish M-Score or its related term are showing as below:

HKSE:01696' s Beneish M-Score Range Over the Past 10 Years
Min: -2.83   Med: -2.25   Max: -2.01
Current: -2.68

During the past 10 years, the highest Beneish M-Score of Sisram Medical was -2.01. The lowest was -2.83. And the median was -2.25.


Sisram Medical Beneish M-Score Historical Data

The historical data trend for Sisram Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical Beneish M-Score Chart

Sisram Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.40 -2.83 -2.02 -2.01 -2.68

Sisram Medical Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.02 - -2.01 - -2.68

Competitive Comparison of Sisram Medical's Beneish M-Score

For the Medical Devices subindustry, Sisram Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sisram Medical's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sisram Medical's Beneish M-Score falls into.



Sisram Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sisram Medical for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9192+0.528 * 0.9337+0.404 * 1.0504+0.892 * 1.0168+0.115 * 1.0403
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2217+4.679 * -0.020272-0.327 * 0.9935
=-2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$657 Mil.
Revenue was HK$2,806 Mil.
Gross Profit was HK$1,714 Mil.
Total Current Assets was HK$2,010 Mil.
Total Assets was HK$4,791 Mil.
Property, Plant and Equipment(Net PPE) was HK$491 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$111 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,245 Mil.
Total Current Liabilities was HK$689 Mil.
Long-Term Debt & Capital Lease Obligation was HK$278 Mil.
Net Income was HK$246 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$343 Mil.
Total Receivables was HK$703 Mil.
Revenue was HK$2,760 Mil.
Gross Profit was HK$1,574 Mil.
Total Current Assets was HK$1,951 Mil.
Total Assets was HK$4,326 Mil.
Property, Plant and Equipment(Net PPE) was HK$406 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$97 Mil.
Selling, General, & Admin. Expense(SGA) was HK$1,002 Mil.
Total Current Liabilities was HK$624 Mil.
Long-Term Debt & Capital Lease Obligation was HK$255 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(657.226 / 2805.999) / (703.208 / 2759.769)
=0.234222 / 0.254807
=0.9192

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1574.41 / 2759.769) / (1714.446 / 2805.999)
=0.570486 / 0.610993
=0.9337

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2009.844 + 491.307) / 4791.328) / (1 - (1950.749 + 406.413) / 4325.576)
=0.477984 / 0.455064
=1.0504

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2805.999 / 2759.769
=1.0168

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(96.555 / (96.555 + 406.413)) / (111.173 / (111.173 + 491.307))
=0.19197 / 0.184526
=1.0403

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1245.171 / 2805.999) / (1002.44 / 2759.769)
=0.443753 / 0.363233
=1.2217

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((277.592 + 689.215) / 4791.328) / ((254.723 + 623.805) / 4325.576)
=0.201783 / 0.203101
=0.9935

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(246.001 - 0 - 343.131) / 4791.328
=-0.020272

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sisram Medical has a M-score of -2.68 suggests that the company is unlikely to be a manipulator.


Sisram Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Sisram Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sisram Medical (HKSE:01696) Business Description

Traded in Other Exchanges
N/A
Address
HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.
Executives
Fosun Holdings Limited
Fosun International Holdings Ltd.
Fosun International Limited
Guo Guangchang
Ample Up Limited
Fosun Industrial Co., Limited
Shanghai Fosun High Technology (group) Co., Ltd.
Shanghai Fosun Pharmaceutical (group) Co., Ltd.
Chindex Medical Limited

Sisram Medical (HKSE:01696) Headlines

No Headlines